Opinion: Reviewing Reviewers

Science needs a standard way to evaluate and reward journal reviewers.

Written byDavid Cameron Duffy
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, AREYNRefereeing or reviewing manuscripts for scientific journals is at the heart of science, despite its occasional imperfections. Reviewing is a check of quality, originality, impact, and even honesty for papers submitted to scientific journals. Unfortunately, referees are sort of like sperm donors: they are anonymous and their pleasure, if any, is in the process, not the result. No one acknowledges their contributions, except perhaps in small print at the back of a journal at the end of the year. Who in their right mind would want to referee? It takes lots of time to do well and gets no credit. The result is a refereeing crisis.

Various methods have been suggested to improve the situation. Some of these suffer from an approach that punishes reviewers for poor performance, rather than rewarding them for their hard work. Others involve complicated systems of payment or reciprocal altruism where reviewers are rewarded with access to journals that they may or may not be interested in submitting papers to.

I believe being asked to referee reflects one’s true standing in a field. Journal editors will always try to get the most knowledgeable and competent referees possible. I would suggest we build on existing impact measurements to encourage enlightened self-interest. For authors, we have a measure of impact, such as the commonly used h-index, a reflection of publications and citations. For journals, we have impact factors. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies